Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 10:2018:9572805.
doi: 10.1155/2018/9572805. eCollection 2018.

Ahmed Glaucoma Valve Implantation in Vitrectomized Eyes

Nimet Yeşim Erçalık  1 , Serhat İmamoğlu  1
Affiliations

Ahmed Glaucoma Valve Implantation in Vitrectomized Eyes

Nimet Yeşim Erçalık et al. J Ophthalmol. .

Abstract

Purpose: To evaluate the outcomes of Ahmed glaucoma valve (AGV) implantation in vitrectomized eyes.

Materials and methods: The medical records of 13 eyes that developed glaucoma due to emulsified silicon oil or neovascularization following pars plana vitrectomy and underwent AGV implantation were retrospectively reviewed. The main outcome measures were intraocular pressure (IOP), best-corrected visual acuity (BCVA), number of antiglaucoma medications, and postoperative complications. Surgical success was defined as last IOP ≤21 mmHg or ≥6 mmHg and without loss of light perception.

Results: The mean follow-up duration was 11.7 ± 5.5 (range, 6-23) months. The mean IOP before the AGV implantation was 37.9 ± 6.7 mmHg with an average of 3.5 ± 1.2 drugs. At the final visit, the mean IOP was 15.9 ± 4.6 mmHg (p=0.001) and the mean number of glaucoma medications decreased to 2.3 ± 1.3 (p=0.021). At the last visit, 11 eyes (84.4%) had stable or improved VA and one eye (7.7%) had a final VA of no light perception. Surgical success was achieved in 11 of the 13 eyes (84.4%). Postoperative complications were bleb encapsulation (69.2%), early hypotony (38.5%), hyphema (23.1%), decompression retinopathy (23.1%), choroidal detachment (15.4%), intraocular hemorrhage (7.7%), and late endophthalmitis (7.7%). One eye (7.7%) was enucleated because of late endophthalmitis.

Conclusions: Despite complications necessitating medical and surgical interventions, vitrectomized eyes were effectively managed with AGV implantation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Visual gain/loss of the study patients postoperatively.
Figure 2
Figure 2
Fundus examination showing scattered retinal hemorrhages in the periphery and posterior pole typical for decompression retinopathy.
See this image and copyright information in PMC

References

    1. Nguyen Q. H., Lloyd M. A., Heuer D. K., Baerveldt G., Lean J. S., Liggett P. E. Incidence and management of glaucoma after intravitreal silicone oil injection for complicated retinal detachments. 1992;99(10):1520–1526. doi: 10.1016/s0161-6420(92)31771-3. - DOI - PubMed
    1. Nowack C., Lucke K., Laqua H. Removal of silicone oil in treatment of so-called emulsification glaucoma. 1992;89(6):462–464. - PubMed
    1. Gedde S. J. Management of glaucoma after retinal detachment surgery. 2002;13(2):103–109. doi: 10.1097/00055735-200204000-00009. - DOI - PubMed
    1. Vasconcelos-Santos D. V., Nehemy P. G., Schachat A. P., Nehemy M. B. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide incidence and risk factors. 2008;28(4):573–580. doi: 10.1097/iae.0b013e31816079e8. - DOI - PubMed
    1. Scott I. U., Gedde S. J., Budenz D. L., et al. Baerveldt drainage implants in eyes with a pre-existing buckle. 2000;118(11):1509–1513. doi: 10.1001/archopht.118.11.1509. - DOI - PubMed

LinkOut - more resources